Alkermes Plc (ALKS)
42.77
+1.02
(+2.44%)
USD |
NASDAQ |
Oct 05, 16:00
42.77
0.00 (0.00%)
After-Hours: 19:42
Alkermes Enterprise Value : 7.911B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 7.911B |
| October 01, 2026 | 7.708B |
| September 30, 2026 | 7.705B |
| September 29, 2026 | 7.752B |
| September 28, 2026 | 7.643B |
| September 25, 2026 | 7.760B |
| September 24, 2026 | 7.750B |
| September 23, 2026 | 7.974B |
| September 22, 2026 | 8.169B |
| September 21, 2026 | 8.318B |
| September 18, 2026 | 8.186B |
| September 17, 2026 | 8.742B |
| September 16, 2026 | 8.635B |
| September 15, 2026 | 8.628B |
| September 14, 2026 | 8.594B |
| September 11, 2026 | 8.618B |
| September 10, 2026 | 8.641B |
| September 09, 2026 | 8.522B |
| September 08, 2026 | 8.537B |
| September 04, 2026 | 8.640B |
| September 03, 2026 | 8.770B |
| September 02, 2026 | 8.911B |
| September 01, 2026 | 8.824B |
| August 31, 2026 | 8.789B |
| August 28, 2026 | 8.859B |
| Date | Value |
|---|---|
| August 27, 2026 | 9.109B |
| August 26, 2026 | 9.152B |
| August 25, 2026 | 9.161B |
| August 24, 2026 | 9.104B |
| August 21, 2026 | 9.013B |
| August 20, 2026 | 8.961B |
| August 19, 2026 | 9.323B |
| August 18, 2026 | 9.206B |
| August 17, 2026 | 9.268B |
| August 14, 2026 | 9.136B |
| August 13, 2026 | 9.201B |
| August 12, 2026 | 9.340B |
| August 11, 2026 | 9.161B |
| August 10, 2026 | 9.193B |
| August 07, 2026 | 9.154B |
| August 06, 2026 | 9.020B |
| August 05, 2026 | 9.228B |
| August 04, 2026 | 9.238B |
| August 03, 2026 | 9.214B |
| July 31, 2026 | 9.124B |
| July 30, 2026 | 9.298B |
| July 29, 2026 | 9.015B |
| July 28, 2026 | 9.377B |
| July 27, 2026 | 9.750B |
| July 24, 2026 | 9.777B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amarin Corp. Plc | -50.22M |
| Prothena Corp. Plc | 151.38M |
| Biogen, Inc. | 39.55B |
| Exelixis, Inc. | 13.86B |
| Incyte Corp. | 18.68B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.501M |
| Revenue (Quarterly) | 496.01M |
| Total Expenses (Quarterly) | 495.51M |
| EPS Diluted (Quarterly) | 0.0029 |
| Gross Profit Margin (Quarterly) | 75.30% |
| Profit Margin (Quarterly) | 0.10% |
| Earnings Yield | 0.90% |
| Operating Earnings Yield | 1.98% |
| Normalized Earnings Yield | 1.149 |